Prospects for combining hormonal and nonhormonal growth factor inhibition.
Year: 2001
Type: article
Source: PubMed
Authors: A E Wakeling, R I Nicholson, J M Gee
Institution: AstraZeneca (United Kingdom)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: combination therapy, EGFR tyrosine kinase inhibitors, gefitinib, tamoxifen resistance, breast cancer, estrogen receptor-negative breast cancer, hormone-resistant breast cancer, epidermal growth factor receptor, ERBB2, trastuzumab, mitogen-activated protein kinase, fulvestrant, antiestrogen therapy, growth factor receptors, MCF-7 cells
Open Access status: closed
OpenAlex ID: W2104524515
